Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Techride -- Ignore unavailable to you. Want to Upgrade?

To: levy who wrote (4073)	9/11/1999 8:02:00 PM
From: DanZ	Respond to of 7442

Hi Levy, Sorry for answering for Bo, but more than likely he searched for GUMM on SI. Bo's a bit exuberant about GUMM, but I think it's for good reason. IMO, the stock will be a big winner over the next year. I urge everyone to do their own research, but I think the stock will make patient longs a lot of money. Several things are coming together for GumTech in the short term, including excellent sales of Zicam to retailers and a possible nicotine gum and dental gum contract. The New England Journal of Medicine may also accept the first clinical study for Zicam soon, and if they do, the stock should rally several points in a manner similar to VPHM. The high short interest makes GUMM a time bomb and good news will be the catalyst that pulls the plug. My short term target is 18 to 20 and I think the stock has a good shot at 28 to 32 by the end of the year. Best of luck, Dan